‘Considerable increase’ in pay-for-delay settlements: FTC report
24-05-2019
Pay-for-delay settlements fall for second year: FTC report
06-11-2017
14-01-2016
Rrraum / Shutterstock.com
Pharmaceutical companies have entered into fewer ‘pay-for-delay’ patent settlements since the US Supreme Court said such agreements could violate anti-competition laws, a report has claimed.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Actavis, US Supreme Court, Federal Trade Commission, pay-for-delay, FTC, patent settlement, patent litigation